Driven by Science. Focused on Patients.
CSS Pharma pioneers biopharmaceutical research to address rare diseases with the highest unmet need.
Our Mission
To discover, develop and deliver transformative medicines for patients with rare diseases
Our Focus
Develop treatment options for patients with rare diseases with high unmet need. There are more than 1200 rare diseases. In total, they affect 300-400 millions of people, but less than 5% of rare diseases have FDA-approved therapies to treat and/or manage this class of conditions.
By capitalizing on scientific advancements that deepen our understanding of rare diseases, we have the potential to develop breakthrough medicines for patients in need at an unprecedented scale.
Our Platform
Our drug engineering platform leverages and efficiently translates innovation into therapies that matter.
Driven by innovative approaches
Enabled by cutting-edge R&D practices
Informed by clinical and real-world evidence
focused on rare diseases with the highest patient need
CSS Pipeline
Programs
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approval
CSS - 1
Hemiplegic Migraine
CSS - 2
Idiopathic pulmonary fibrosis
CSS - 3
Pulmonary Sarcoidosis
CSS - 4*
Other Programs
*Includes other undisclosed rare disease assets under development
Our Values
Patients First Approach
CSS Pharma ultimately exists to serve patients.
Around the world, millions suffer from rare diseases, yet small patient populations and limited industry investment in early-stage development have left many without effective treatments. we are committed to closing this gap: bridging science and possibility, innovation and access, patient and hope. Our mission begins with our first core value: Put patients first.
Every Minute Matters
For patients living with rare diseases, time is critical. We work with urgency and precision, streamlining processes to bring therapies to those in need as quickly as possible.
Let Data Lead
Our science is guided by evidence. From clinical trials to real-world data, we rely on rigorous analysis to inform decisions and ensure that our innovations deliver meaningful impact.
Think Boldly
For patients living with rare diseases, time is critical. We work with urgency and precision, streamlining processes to bring therapies to those in need as quickly as possible.
Act Transparently
Trust is built on openness. We share our progress, challenges, and decisions with patients, partners, and investors to ensure clarity and accountability at every stage of development.
CSS Pharma is committed to developing innovators as well as medicines.
We seek partners whose passion for transforming the lives of rare disease patients drives hands-on engagement and the relentless pursuit of breakthrough solutions in the face of challenge.